Outlook Therapeutics, Inc. (OTLK) › Cost of RevenueOutlook Therapeutics, Inc. (OTLK) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearCost of RevenueChange YoY2025$1.36M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share